Skip to content

Evolving the Flatiron Brand. Read more.

An evaluation of the impact of missing deaths on overall survival analyses of advanced non-small cell lung cancer patients conducted in an electronic health records database

March 15, 2019

Our summary

Researchers from Roche and Flatiron Health performed a deep dive into evaluating the impact of missingness in our mortality dataset. The findings, using National Death Index data up to the end of 2015, suggest that impact on survival analyses is minimal when sensitivity (completeness) of mortality data is high.

This is a follow-up publication to the May 2018 Health Services Research publication which detailed the compilation of our mortality dataset and subsequent benchmarking to the National Death Index, which is considered the national gold standard for death data. This validation based on 2015 data found that Flatiron’s aNSCLC data had a sensitivity of 90 percent.

Why this matters

The quality of real-world evidence in oncology depends on the robustness and reliability of endpoints such as overall survival. This study shows that the highly sensitive Flatiron composite mortality variable can be applied to EHR-derived datasets to yield overall survival estimates that are largely accurate, and subject to negligible bias.

Read the research